The differences of biomechanical parameters among the three groups were compared by the general linear model with adjustment for gender, age, axial length, IOP and CCT. There were statistically significant differences in several parameters between the controls and untreated glaucoma groups (
Table 2). DA was significantly higher whereas AT1 and HC time were significantly lower in NTG (DA = 1.01 ± 0.01 mm, P = 0.001; AT1 = 7.62 ± 0.02 ms,
P < 0.0001; HC time = 16.91 ± 0.10 ms,
P = 0.001) and HTG eyes (DA = 1.02 ± 0.01 mm,
P = 0.002; AT1 = 7.64 ± 0.03 ms,
P < 0.0001; HC time = 16.77 ± 0.10 ms,
P = 0.0002) than in controls (DA = 0.95 ± 0.01 mm; AT1 = 7.82 ± 0.02 ms; HC time = 17.41 ± 0.01 ms). In addition, NTG showed the highest AV1 (0.14 ± 0.01 m/s) compared with controls (0.12 ± 0.01 m/s,
P < 0.0001) and HTG (0.13 ± 0.01 m/s,
P = 0.044). SP-A1 and time of WEM decreased statistically significantly in NTG eyes (SP-A1 = 119.55 ± 3.19 mm Hg/mm; WEM = 22.12 ± 0.18 ms) than in controls (SP-A1 = 132.85 ± 3.02 mm Hg/mm,
P = 0.009; WEM = 22.86 ± 0.17 ms,
P = 0.008). The ocular biomechanical differences between the POAG patients (composed of NTG and HTG) and healthy controls were also analyzed by the general linear model and the results were shown in
Supplementary Table S1. DA (1.02 ± 0.01 vs. 0.95 ± 0.01 mm,
P < 0.0001), AV1 (0.13 ± 0.01 vs. 0.12 ± 0.01 m/s,
P < 0.0001), integrated radius (8.35 ± 0.09 vs. 7.97 ± 0.14 mm
−1,
P = 0.028) and ARTh (449.65 ± 7.11 vs. 420.84 ± 10.44 µm,
P = 0.031) were significantly higher, whereas AT1 (7.62 ± 0.02 vs. 7.82 ± 0.02 ms,
P < 0.0001), AT2 (21.57 ± 0.06 vs. 21.82 ± 0.09 ms,
P = 0.035), HC time (16.87 ± 0.06 vs. 17.40 ± 0.09 ms,
P < 0.0001), SP-A1 (121.97 ± 2.05 vs. 132.82 ± 3.01 mm Hg/mm,
P = 0.005) and time of WEM (22.20 ± 0.11 vs. 22.85 ± 0.17 ms,
P = 0.002) were significantly lower in POAG eyes compared to those in normal controls.